suplatast tosilate has been researched along with Pulmonary Eosinophilia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, T; Hirata, A; Makino, S; Watanabe, N | 1 |
| Arakawa, M; Fujimori, K; Gejyo, F; Shimatsu, Y; Suzuki, E | 1 |
| Ichinose, Y; Kusumoto, H; Mizuno, K; Nakano, M; Toyama, K; Yonemaru, M | 1 |
| Akira, M; Hamada, H; Nakamura, Y; Nishioka, M; Okano, Y; Sakatani, M; Sone, S; Ueda, E; Yamamoto, S | 1 |
| Agrawal, DK; Suwaki, T; Townley, RG | 1 |
5 other study(ies) available for suplatast tosilate and Pulmonary Eosinophilia
| Article | Year |
|---|---|
A case of eosinophilic pneumonia successfully treated with suplatast tosilate alone.
Topics: Aged; Anti-Allergic Agents; Arylsulfonates; Female; Humans; Pulmonary Eosinophilia; Radiography; Sulfonium Compounds; Treatment Outcome; X-Ray Film | 2009 |
[Chronic eosinophilic pneumonia complicated by bronchial asthma and diabetes mellitus successfully treated with suplatast tosilate and high-dose inhaled corticosteroid therapy].
Topics: Administration, Inhalation; Anti-Asthmatic Agents; Arylsulfonates; Asthma; Beclomethasone; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Interleukin-5; Middle Aged; Pulmonary Eosinophilia; Sulfonium Compounds | 1999 |
[Successful treatment of chronic eosinophilic pneumonia with suplatast tosilate].
Topics: Anti-Allergic Agents; Arylsulfonates; Chronic Disease; Female; Humans; Middle Aged; Pulmonary Eosinophilia; Sulfonium Compounds | 1997 |
[Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
Topics: Anti-Allergic Agents; Arylsulfonates; Chronic Disease; Female; Humans; Interleukin-5; Middle Aged; Pulmonary Eosinophilia; Sulfonium Compounds | 1997 |
Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug.
Topics: Anti-Allergic Agents; Arylsulfonates; Asthma; Cell Adhesion; Cells, Cultured; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Endothelium, Vascular; Eosinophils; Gene Expression Regulation; Humans; Integrin alpha4beta1; Integrins; Interleukin-4; Platelet Activating Factor; Pulmonary Eosinophilia; Receptors, Lymphocyte Homing; Respiratory Hypersensitivity; Sulfonium Compounds; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2001 |